A 2026 randomized controlled trial of 18,205 older adults found that daily multivitamins did not prevent COVID-19 infections, with similar infection rates between the multivitamin and placebo groups. However, among people who did get infected, those taking multivitamins showed a promising signal of 30-40% lower odds of developing symptomatic COVID-19, though this finding wasn’t statistically certain. According to Gram Research analysis, multivitamins appear ineffective for COVID-19 prevention but may help reduce symptom severity if infection occurs.
Researchers studied whether taking a daily multivitamin could help prevent COVID-19 or reduce how sick people got. They followed over 18,000 healthy older adults for a year during the pandemic, with some taking multivitamins and others taking a placebo. According to Gram Research analysis, the multivitamin didn’t prevent COVID-19 infections, but it showed a promising signal for reducing severe symptoms in people who did get infected. The findings suggest multivitamins alone aren’t a COVID-19 prevention tool, but they might help people feel less sick if they catch the virus.
Key Statistics
A 2026 randomized controlled trial of 18,205 older American adults found that daily multivitamin supplementation did not significantly reduce COVID-19 infection rates, with 786 infections occurring equally between the multivitamin and placebo groups during 2020.
Among 338 COVID-19 cases with detailed symptom data in the COSMOS trial, participants taking multivitamins had 30-40% lower odds of developing symptomatic COVID-19 compared to placebo, though this promising finding was not statistically definitive.
In the COSMOS study’s per-protocol analysis of consistently adherent participants, the odds ratio for symptomatic COVID-19 was 0.60 comparing multivitamin to placebo, suggesting a potential 40% reduction in symptom development among those who took their supplements regularly.
The Quick Take
- What they studied: Whether taking a daily multivitamin supplement could prevent COVID-19 infections or reduce how severe the illness was in older adults.
- Who participated: 18,205 healthy American adults aged 50 and older who were part of a larger health study. About 786 of them caught COVID-19 during 2020, with roughly equal numbers in the multivitamin and placebo groups.
- Key finding: Multivitamins didn’t prevent COVID-19 infections (93% of the infection rate in the multivitamin group compared to placebo). However, among people who got infected, those taking multivitamins had about 30-40% lower odds of developing symptomatic COVID-19, though this result wasn’t statistically certain.
- What it means for you: Taking a daily multivitamin won’t protect you from catching COVID-19. However, if you do get infected, a multivitamin might help reduce your symptoms. This is a promising signal but not definitive proof, so don’t rely on multivitamins as your main COVID-19 prevention strategy. Vaccination and other proven preventive measures remain more important.
The Research Details
This was a secondary analysis of the COSMOS trial, a large, rigorous study that started in 2015 to test whether multivitamins and cocoa extract could prevent heart disease and cancer. The study was “double-blinded,” meaning neither the participants nor the researchers knew who was taking the real multivitamin and who was taking a placebo (fake pill). This design prevents bias from affecting the results.
When COVID-19 emerged in 2020, researchers used the final year of this ongoing study to examine whether multivitamins affected COVID-19 outcomes. They tracked participants from January through December 2020, recording who got infected, who had symptoms, and how many symptoms they experienced. The study included 18,205 people who were actively taking their assigned pills at the start of 2020.
Researchers analyzed the data two ways: first, they included everyone who was assigned to each group (intention-to-treat), and second, they looked only at people who consistently took their pills as directed (per-protocol). This approach helps determine whether the supplement itself works or whether taking it matters.
This study design is important because it’s a randomized controlled trial, which is the gold standard for testing whether something actually works. By randomly assigning people to multivitamin or placebo groups and keeping everyone blinded, the researchers eliminated most sources of bias. The large sample size (18,205 people) means the results are more reliable than smaller studies. Additionally, the study captured real-world COVID-19 infections during the actual pandemic, making the findings relevant to what actually happened.
This study has several strengths: it’s a large, well-designed randomized controlled trial published in a respected journal (American Journal of Clinical Nutrition); it used a true placebo control; participants were tracked throughout 2020 with confirmed COVID-19 cases; and the researchers pre-specified their main questions before analyzing the data. However, the study was limited to older, generally healthy adults, mostly white and well-educated, so results may not apply to younger people or those with chronic diseases. Additionally, COVID-19 cases were self-reported or diagnosed by doctors, which could introduce some inaccuracy.
What the Results Show
Among the 18,205 participants, 786 reported COVID-19 infections during 2020 (382 in the multivitamin group and 404 in the placebo group). The multivitamin group had a 7% lower infection rate compared to placebo, but this difference was small and could have occurred by chance. Statistically, the researchers couldn’t confidently say the multivitamin prevented COVID-19.
When looking at people who actually got infected, the picture became more interesting. Among 338 people with detailed symptom information, those taking multivitamins had lower odds of developing symptomatic COVID-19 (meaning they had fewer or no symptoms). In the most rigorous analysis (looking only at people who took their pills consistently), the multivitamin group had 40% lower odds of symptomatic illness compared to placebo.
However, this promising finding came with an important caveat: the confidence interval included the possibility of no effect, meaning researchers couldn’t be completely certain the difference was real rather than due to chance. The study also found that among symptomatic cases, the multivitamin group reported slightly fewer symptoms on average, though the difference was modest.
The study examined symptom severity and symptom count among people who got COVID-19. Those taking multivitamins reported fewer total symptoms and potentially less severe illness, though these differences were not statistically significant in all analyses. The findings suggest that if multivitamins do help, the benefit appears to be in reducing symptom severity rather than preventing infection altogether. This pattern makes biological sense, as multivitamins support immune function, which might help your body fight the virus more effectively once infected.
Previous research on multivitamins and respiratory infections has shown mixed results. Some studies suggested that certain vitamins (like vitamin D and zinc) might reduce respiratory infection risk, but evidence for comprehensive multivitamins was limited. This COSMOS study is one of the largest and most rigorous examinations of multivitamins and COVID-19 specifically. The finding that multivitamins don’t prevent infection aligns with most previous research on multivitamins and infection prevention, but the signal for reducing symptom severity is relatively novel and warrants further investigation.
Several limitations affect how we should interpret these findings. First, COVID-19 cases were self-reported or based on doctor diagnoses, not all confirmed by laboratory testing, which could introduce errors. Second, the study population was older (average age 67), mostly white, and generally healthy, so results may not apply to younger people, other racial/ethnic groups, or people with chronic diseases. Third, the promising finding about symptom reduction wasn’t statistically certain, meaning it could have been due to chance. Fourth, the study couldn’t determine which specific vitamins or minerals in the multivitamin might have been responsible for any benefits. Finally, the study only lasted one year, so long-term effects remain unknown.
The Bottom Line
Based on this research, multivitamins are not recommended as a COVID-19 prevention strategy (low confidence). However, if you’re already taking a multivitamin for other health reasons, the research suggests it may help reduce symptom severity if you do get infected (moderate confidence, but not definitive). Continue following proven COVID-19 prevention measures: vaccination, testing when symptomatic, and isolation if infected. If you’re considering starting a multivitamin, discuss it with your doctor to ensure it’s appropriate for your individual health situation.
This research is most relevant to older adults (50+) who are generally healthy and wondering whether to take multivitamins. The findings don’t apply strongly to younger people, those with chronic diseases, or immunocompromised individuals, as the study didn’t include these groups. People who are already taking multivitamins for other health reasons can feel reassured that the supplements won’t interfere with COVID-19 prevention, though they shouldn’t rely on them as protection. Healthcare providers may find this useful when counseling patients about supplement use during respiratory illness seasons.
If multivitamins do help reduce COVID-19 symptom severity, the benefit would likely appear within the first few days of infection, as that’s when symptoms typically develop. However, this research doesn’t establish a clear timeline, and the effect size was modest. Don’t expect dramatic symptom reduction; any benefit appears to be relatively small.
Frequently Asked Questions
Can multivitamins prevent COVID-19 infection?
No, according to a 2026 trial of 18,205 adults, daily multivitamins did not reduce COVID-19 infection rates compared to placebo. Vaccination and other proven preventive measures remain more effective for preventing infection.
Do multivitamins help if you already have COVID-19?
Possibly. Research shows people taking multivitamins had 30-40% lower odds of developing severe symptoms if infected, but this finding wasn’t statistically certain. The effect appears modest if it exists.
Should I start taking multivitamins to protect against COVID-19?
No, this research doesn’t support starting multivitamins specifically for COVID-19 prevention. Focus on vaccination, testing, and isolation if sick. Discuss multivitamins with your doctor for other potential health benefits.
Who was included in this multivitamin and COVID-19 study?
The study included 18,205 healthy American adults aged 50 and older. Results may not apply to younger people, those with chronic diseases, or immunocompromised individuals who weren’t well-represented in the research.
How long do you need to take multivitamins to see COVID-19 benefits?
The study tracked participants taking multivitamins for years before COVID-19 emerged. If multivitamins help reduce symptoms, the benefit would likely appear during the first few days of infection, not from recent supplement use.
Want to Apply This Research?
- Track daily multivitamin adherence (yes/no) alongside any cold or flu-like symptoms you experience. If you get sick, log symptom severity (mild, moderate, severe) and symptom count daily for 7-10 days to see if your multivitamin use correlates with faster recovery.
- If you’re not currently taking a multivitamin, this research doesn’t provide strong reason to start one specifically for COVID-19 prevention. If you’re already taking one, maintain consistent daily adherence, as the study showed benefits only in people who took their pills regularly. Set a daily reminder at the same time each day to build the habit.
- Use the app to track: (1) daily multivitamin intake (consistency matters), (2) any respiratory symptoms you develop, (3) symptom severity if you get sick, and (4) recovery timeline. Over months, you can see whether consistent multivitamin use correlates with milder illness when you do catch respiratory infections. Share this data with your doctor during annual checkups to inform personalized supplement recommendations.
This research summary is for educational purposes only and should not replace professional medical advice. The findings suggest multivitamins do not prevent COVID-19 infection but may help reduce symptom severity if infection occurs—however, this benefit was not statistically certain. Do not use multivitamins as your primary COVID-19 prevention strategy. Vaccination remains the most effective protection against COVID-19. Consult your healthcare provider before starting any new supplement regimen, especially if you have chronic health conditions, take medications, or are immunocompromised. This study was conducted in older, generally healthy adults and may not apply to all populations.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.